Live Birth in Woman With Premature Ovarian Insufficiency Receiving Ovarian Administration of Platelet-Rich Plasma (PRP) in Combination With Gonadotropin: A Case Report
暂无分享,去创建一个
[1] V. Harris,et al. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review. , 2019, Reproductive biomedicine online.
[2] M. Koutsilieris,et al. Autologous Platelet-Rich Plasma Treatment Enables Pregnancy for a Woman in Premature Menopause , 2018, Journal of clinical medicine.
[3] M. Hammar,et al. The prevalence of primary ovarian insufficiency in Sweden; a national register study , 2018, BMC Women's Health.
[4] F. Albuz,et al. Low Gonadotropin Dosage Reduces Aneuploidy in Human Preimplantation Embryos: First Clinical Study in a UAE Population. , 2018, Genetic testing and molecular biomarkers.
[5] M. Koutsilieris,et al. A Case Series on Platelet-Rich Plasma Revolutionary Management of Poor Responder Patients , 2018, Gynecologic and Obstetric Investigation.
[6] Yue-ting Zhu,et al. Dosage of exogenous gonadotropins is not associated with blastocyst aneuploidy or live-birth rates in PGS cycles in Chinese women , 2018, Human reproduction.
[7] G. Muschler,et al. Variability in the Preparation, Reporting, and Use of Bone Marrow Aspirate Concentrate in Musculoskeletal Disorders: A Systematic Review of the Clinical Orthopaedic Literature , 2018, The Journal of bone and joint surgery. American volume.
[8] G. Palermo,et al. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma , 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[9] K. Ivani,et al. High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer , 2017, Human reproduction.
[10] G. Muschler,et al. A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting: A Systematic Review of the Clinical Orthopaedic Literature , 2017, The Journal of bone and joint surgery. American volume.
[11] M. Akhondi,et al. Platelet-rich plasma promotes the development of isolated human primordial and primary follicles to the preantral stage. , 2017, Reproductive biomedicine online.
[12] B. Fauser,et al. Ovarian stimulation protocols for IVF: is more better than less? , 2017, Reproductive biomedicine online.
[13] M. Polak,et al. Long‐term outcome of ovarian function in women with intermittent premature ovarian insufficiency , 2017, Clinical endocrinology.
[14] R. Cífková,et al. ESHRE Guideline: management of women with premature ovarian insufficiency. , 2016, Human Reproduction.
[15] Trine Høyer Rose,et al. Population Pharmacokinetic Modelling of FE 999049, a Recombinant Human Follicle-Stimulating Hormone, in Healthy Women After Single Ascending Doses , 2016, Drugs in R&D.
[16] Yuan Cheng,et al. Intraovarian control of early folliculogenesis. , 2015, Endocrine reviews.
[17] R. Dhurat,et al. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective , 2014, Journal of cutaneous and aesthetic surgery.
[18] Liying Yan,et al. Basic fibroblast growth factor promotes the development of human ovarian early follicles during growth in vitro. , 2014, Human reproduction.
[19] Y. Morimoto,et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment , 2013, Proceedings of the National Academy of Sciences.
[20] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[21] J. Golmard,et al. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. , 2011, The Journal of clinical endocrinology and metabolism.
[22] Chao-Chin Hsu,et al. Abdominal mesotherapy injection extended the absorption of follicle-stimulating hormone. , 2011, Fertility and sterility.
[23] A. Shelling. Premature ovarian failure. , 2010, Reproduction.
[24] Shu Liu,et al. Activation of dormant ovarian follicles to generate mature eggs , 2010, Proceedings of the National Academy of Sciences.
[25] A. Gougeon. Human ovarian follicular development: from activation of resting follicles to preovulatory maturation. , 2010, Annales d'endocrinologie.
[26] Chao-Chin Hsu,et al. The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections - a pharmacokinetic study , 2009, Reproductive biology and endocrinology : RB&E.
[27] S. Wang,et al. Intermittent vaginal injections of gonadotrophins for ovarian stimulation in IVF treatment. , 2008, Reproductive biomedicine online.
[28] David Handelsman,et al. Follicle-stimulating hormone increases primordial follicle reserve in mature female hypogonadal mice. , 2006, The Journal of endocrinology.
[29] S. Hawes,et al. Development of spare human preimplantation embryos in vitro: An analysis of the correlations among gross morphology, cleavage rates, and development to the blastocyst , 1989, Journal of in Vitro Fertilization and Embryo Transfer.
[30] A. Munafo,et al. The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women. , 1998, British journal of clinical pharmacology.
[31] K. Oktay,et al. Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. , 1997, The Journal of clinical endocrinology and metabolism.
[32] Rw Rebar,et al. Clinical features of young women with hypergonadotropic amenorrhea , 1990, Fertility and sterility.
[33] J. Annegers,et al. Incidence of Premature Ovarian Failure , 1986, Obstetrics and gynecology.